Legacy medical device security still depends on inventory and isolation

At a glance

What this is: This is an analysis of why legacy medical devices are uniquely hard to secure and which manufacturer and healthcare-operator steps can reduce risk.

Why it matters: It matters because HDOs, security teams, and compliance leads must treat device security as an operational and patient-safety issue, not just a patching problem.

By the numbers:

• The average ransomware incident requires 30 days to recover.
• Medical device regulations include section 524B of the Federal Food, Drug, and Cosmetic Act.

👉 Read Kusari's analysis of legacy medical device security and lifecycle risk

Context

Legacy medical devices create a governance gap because they are expensive, long-lived, and often difficult to patch or replace once they are deployed. In practice, that means security teams are dealing with unsupported software, limited remediation options, and operational pressure to keep care flowing even when vulnerabilities are known.

The primary identity angle is not human IAM but device and system trust, including access to clinical data, connected infrastructure, and external media. That makes inventory, network segmentation, and lifecycle oversight the practical controls that determine whether a weak device becomes an enterprise-wide operational risk.

Key questions

Q: What breaks when legacy medical devices are not inventoried and segmented properly?

A: Without inventory and segmentation, security teams cannot identify where old devices sit, what they can reach, or how to contain a compromise. That turns a single vulnerable device into a hospital-wide risk because remediation becomes reactive and clinical downtime becomes more likely.

Q: Why do legacy medical devices create a different risk model from ordinary IT assets?

A: Legacy medical devices can affect patient safety directly, remain in use long after vendor support ends, and may be difficult or impossible to patch. That means risk decisions must account for continuity of care, not just confidentiality and availability in the usual IT sense.

Q: How do you know whether medical device security controls are actually working?

A: Look for a current inventory, verified network segmentation, documented end-of-life status, and tested fallback procedures. If teams cannot quickly answer where devices are, what they connect to, and how care continues during outage, the controls are not mature enough.

Q: Who is accountable when a medical device cyber issue affects patient safety?

A: Accountability sits with the manufacturer for ensuring cybersecurity does not compromise clinical performance, but healthcare operators also need ownership for deployment, monitoring, and maintenance. The practical question is not who caused the weakness alone, but who controls the patch path, the risk decision, and the response when patient harm becomes plausible.

Technical breakdown

Why legacy medical device risk persists after support ends

Legacy medical devices are difficult to secure because their lifecycle is much longer than the patching horizon of the software inside them. Many systems run older C or C++ code, where memory-safety flaws remain common and source code may no longer exist. That combination makes remediation slow, incomplete, or impossible. In healthcare, the problem is amplified by patient-safety constraints, because a failed patch can interrupt clinical workflows or introduce new hazards. The result is a security model that must assume some devices will remain exposed for years.

Practical implication: build controls around device containment and compensating safeguards, not just patch delivery.

How inventory and segmentation reduce the blast radius

A complete device inventory is the foundation for containment because you cannot protect what you cannot locate. Once devices are identified, segmentation limits where a vulnerable system can communicate and prevents one compromise from spreading into broader hospital networks. The article also points to restricting removable media where it is not needed, which matters because USB paths often bypass normal network controls. This is less about hardening every device equally and more about reducing reachable attack paths around systems that cannot be fully remediated.

Practical implication: map device locations, dependencies, and network paths before a vulnerability forces emergency isolation.

Why continuity planning is part of medical device security

Medical device security is inseparable from continuity of care because downtime affects treatment, scheduling, and in some cases patient safety. A ransomware event can push providers back to paper processes, while a compromised device may need to be isolated before the impact is fully understood. That means incident plans must address containment, manual workarounds, and restoration in clinical terms, not only in IT service terms. For health delivery organisations, resilience is a control, not an afterthought.

Practical implication: test patient-care fallback procedures alongside technical incident response playbooks.

Threat narrative

Attacker objective: The attacker seeks to use an exposed medical device as a route to disruption, data access, or unsafe treatment conditions.

1. Entry occurs through vulnerable legacy medical devices or connected systems that are already deployed in the field and difficult to patch quickly.
2. Escalation happens when a compromised device becomes a foothold into adjacent hospital systems or forces unsafe fallback workflows.
3. Impact is clinical disruption, data exposure, or direct patient harm if treatment systems are altered or taken offline.

NHI Mgmt Group analysis

Legacy medical device security is a lifecycle governance problem, not a patching problem. The article shows that the hardest part is not identifying a vulnerability, but governing equipment that may remain in service long after support ends. That is a lifecycle issue shared with identity and access systems: unmanaged longevity creates unmanaged risk. Practitioners should treat end-of-life visibility as a security control, not an asset-management nicety.

Device inventory is the control that makes every other safeguard possible. If health delivery organisations cannot identify where devices live, what they connect to, and when support ended, then segmentation and mitigation will always be partial. In identity programmes, the same principle applies to service accounts and workload identities: what is not inventoried cannot be governed. The named concept here is unsupported device persistence, and it is a predictable failure mode whenever lifecycle ownership is unclear. Practitioners should make device discovery continuous.

Clinical resilience must be designed into security planning. The article correctly frames patient outcomes as the real cost of security failure, because a device outage can force slower manual procedures and increase error rates. That means security and operations teams need joint ownership of containment, fallback workflows, and restoration criteria. Security programmes that stop at technical hardening miss the operational reality of healthcare environments. Practitioners should align device controls with continuity-of-care planning.

Manufacturers and operators both carry accountability for legacy exposure. The article makes clear that manufacturers need to share vulnerability information and criteria for exceptional patch support, while HDOs need inventory, segmentation, and information-sharing participation. That shared responsibility mirrors identity governance, where technology owners and business owners both contribute to risk reduction. Practitioners should formalise who is responsible for each stage of the device lifecycle, especially when support has already lapsed.

What this signals

Unsupported device persistence: Legacy healthcare assets create the same lifecycle blind spot that NHI programmes face when credentials and devices remain active beyond their intended operating window. Security teams should treat support status as a live control, not a static attribute, and pair it with [The 52 NHI breaches Report](https://nhimg.org/52-non-human-identity-breaches) to understand how neglected lifecycle governance turns into exposure.

The next maturity step is less about perfect patch coverage and more about proving containment. That means verifying that vulnerable devices cannot freely traverse networks, removable media cannot bypass policy, and clinical fallback plans work under pressure.

For programmes already tracking identity and access risk, the lesson is straightforward: visibility first, containment second, and remediation only where the device can safely absorb it. The organisations that operationalise this sequence will be better prepared for both security audits and real clinical disruption.

For practitioners

• Build a complete device inventory Record every medical device’s location, network dependencies, support status, and end-of-life date so containment decisions can be made before an incident forces emergency isolation.
• Segment legacy devices by clinical function Place older devices into restricted network zones and limit east-west connectivity so a compromise does not spread into EHR systems, imaging systems, or broader hospital infrastructure.
• Restrict removable media where it is unnecessary Apply policies that block USB mounting on devices that do not require external storage, because removable media often becomes a bypass path around network protections.
• Participate in healthcare vulnerability sharing groups Join manufacturer or sector information-sharing channels so mitigation guidance and workaround details arrive before the device is actively exploited.
• Test continuity-of-care fallback procedures Exercise manual workflows, containment steps, and recovery criteria for device outages so clinical teams can keep care moving if a system must be taken offline.

Key takeaways

• Legacy medical devices are hard to secure because long lifecycles, old code, and missing source code make traditional patching unreliable.
• The most practical controls are inventory, segmentation, media restriction, and continuity planning because they reduce blast radius when remediation is limited.
• Security ownership must be shared across manufacturers, HDOs, and governance teams or legacy exposure will persist until an incident forces action.

Key terms

• Legacy Medical Device: A legacy medical device is a clinical system that remains in use after its original support window, often with limited patching options and older software dependencies. These devices can be technically functional while still carrying elevated security and safety risk because lifecycle management has drifted behind operational use.
• Unsupported Device Persistence: Unsupported device persistence is the condition where ageing hardware continues to operate after vendor support has expired. The risk is not just outdated software but the organisational assumption that continued functionality equals acceptable security, which often leaves compensation controls underdeveloped.
• Clinical Containment: Clinical containment is the process of limiting the spread and operational impact of a compromised healthcare device while preserving patient care. It combines segmentation, isolation, fallback workflows, and recovery planning so that security actions do not create avoidable treatment disruption.

What's in the full article

Kusari's full article covers the operational detail this post intentionally leaves for the source:

• Manufacturer-side guidance on sharing newly discovered vulnerabilities with device owners and health delivery organisations
• Criteria for deciding when an end-of-life device still deserves exceptional patch support
• Trade-in incentive considerations for retiring unsupported medical devices from the field
• Practical examples of how inventory, segmentation, and information-sharing groups can be used together

👉 Kusari's full article covers manufacturer actions, HDO controls, and continuity planning details

Deepen your knowledge

The NHI Foundation Level course, the industry's only accredited NHI security programme, covers NHI governance, secrets management, and workload identity in a way that helps practitioners connect lifecycle control to operational risk. It is suited to security and identity teams that need to govern long-lived assets with clear ownership and remediation paths.